1011 1030
International Consultation for Sexual Medicine (ICSM 2015). J Sex
Med 2016;13:465–88.
[43]
Corona G, Giorda CB, Cucinotta D, Guida P, Nada E, SUBITO-DE Study Group. Sexual dysfunction in type 2 diabetes at diagnosis: progression over time and drug and non-drug correlated factors. PLoS One 2016;11:e0157915.[44] Vardi M, Nini A. Phosphodiesterase inhibitors for erectile dysfunc-
tion in patients with diabetes mellitus. Cochrane Database Syst Rev
2007:CD002187.
[45]
Corona G, Giorda CB, Cucinotta D, Guida P, Nada E, Gruppo di studio SUBITO-DE. Sexual dysfunction at the onset of type 2 diabetes: the interplay of depression, hormonal and cardiovascular factors. J Sex Med 2014;11:2065–73.[46]
Corona G, Giagulli VA, Maseroli E, et al. Testosterone supplemen- tation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest 2016;39:967–81.[47]
Corona G, Giagulli VA, Maseroli E, et al. Therapy of endocrine disease: testosterone supplementation and body composition: results from a meta-analysis study. Eur J Endocrinol 2016;174: R99–116.
[48]
Isidori AM, Balercia G, Calogero AE, et al. Outcomes of androgen replacement therapy in adult male hypogonadism: recommenda- tions from the Italian society of endocrinology. J Endocrinol Invest 2015;38:103–12.
[49]
Corona G, Isidori AM, Aversa A, Burnett AL, Maggi M. Endocrinologic control of men’s sexual desire and arousal/erection. J Sex Med 2016;13:317–37.
[50]
Corona G, Jannini EA, Vignozzi L, Rastrelli G, Maggi M. The hormonal control of ejaculation. Nat Rev Urol 2012;9:508–19.[51]
Maggi M, Heiselman D, Knorr J, Iyengar S, Paduch DA, Donatucci CF. Impact of testosterone solution 2% on ejaculatory dysfunction in hypogonadal men. J Sex Med 2016;13:1220–6.E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 1 0 0 0 – 1 0 1 1
1011